SB 2378

relating to a report on governmental opioid antagonist programs to
reverse and prevent opioid overdoses.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1.  Subchapter B, Chapter 461A, Health and Safety
Code, is amended by adding Section 461A.060 to read as follows:
Sec. 461A.060.  BIENNIAL REPORT ON OPIOID ANTAGONIST
PROGRAMS FOR OPIOID OVERDOSE REVERSAL AND PREVENTION.  (a)  In this
section, "opioid antagonist" has the meaning assigned by Section
(b)  Not later than October 1 of each even-numbered year, the
(1)  prepare a report evaluating the distribution of
opioid antagonists in this state to reverse and prevent opioid
(2)  submit the report to the governor, the lieutenant
governor, and the speaker of the house of representatives.
(c)  The report described by Subsection (b) must:
(1)  include a needs assessment for the opioid
antagonist programs established by state agencies and institutions
(2)  establish a statewide saturation goal for opioid
(A)  a description of the data sources and
methodology used to estimate insufficiencies in the current supply
(B)  a communications plan to address opioid
overdoses in areas of this state at higher risk for increased
(3)  include a description of all state and federal
money appropriated to governmental opioid antagonist programs;
(4)  establish opioid antagonist distribution
(5)  list and describe all available state and
federally funded purchase and distribution programs for opioid
(6)  recommend improvements for addressing opioid
overdoses among high-risk populations, including school-aged
children, pregnant and postpartum women, and individuals residing
(d)  In preparing the report under this section, the
commission shall coordinate and consult with each state agency and
institution of higher education that receives funding or other
resources for the distribution of opioid antagonists.
SECTION 2.  This Act takes effect September 1, 2025.